Has Santiago Plurad received payments from drug or device companies?

Yes. Drug and device makers reported $2,208 in general payments to Santiago Plurad across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Santiago Plurad did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Santiago Plurad come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Santiago Plurad

Pediatrics · Saint Louis, MONPI 1215902101

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Tris Pharma Inc at 24.0% of the total. Reporting peaked in 2019 at $1,303 and has fallen 96.9% since, to $40 in 2023. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,208in general payments, 2019–2025

Across 131 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tris Pharma Inc$531
Rhodes Pharmaceuticals L.p.$318
Pfizer$279
Ironshore Pharmaceuticals Inc.$265
Takeda Pharmaceuticals U.S.A., Inc.$207
GSK$168
plus $440 from 9 others

What the payments were for

Food & beverage$2,208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tris Pharma Inc	27	$531
Rhodes Pharmaceuticals L.p.	39	$318
Pfizer	10	$279
Ironshore Pharmaceuticals Inc.	9	$265
Takeda Pharmaceuticals U.S.A., Inc.	8	$207
GSK	4	$168
Neos Therapeutics, LP	16	$156
Adlon Therapeutics L.p.	7	$107
Supernus Pharmaceuticals, Inc.	2	$36
Sanofi Pasteur Inc.	2	$33
AbbVie	2	$30
Cranial Technologies, Inc	2	$28
Sobi, Inc	1	$23
Exact Sciences	1	$17
VOCO America Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,208 in reported general payments places this provider in the 90th percentile of 1,306 pediatrics providers in Missouri.

See all pediatrics providers in Missouri →

Other pediatrics in Saint Louis

Molly FiggemeierSaint Louis$74K
Alexander FaySaint Louis$53K
Natalie GoedekerSaint Louis$17K
Gita MalurSaint Louis$12K
Laura KuenstingSaint Louis$9K
Scott TrailSaint Louis$8K
Donna ManleySaint Louis$6K
Mark LevinSaint Louis$5K
Ann HennesseySaint Louis$5K
Prapti SinghSaint Louis$4K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →